Cadalin, Elisa Y.

HRN: 21-87-50  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2023
CEFUROXIME 750MG (VIAL)
05/26/2023
06/01/2023
IV
750 Mg
Q8H
Community Acquired Pneumonia - Moderate Risk

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines